High-grade adenocarcinoma with focal neuroendocrine differentiation is a rare and aggressive variant characterized by heterogeneous biology, often associated with low or absent prostate-specific antigen (PSA) expression, visceral metastases, and partial androgen receptor (AR) independence. Here, AR is linked to adenocarcinoma.